Gwendolyn Y. Gresham's most recent trade in Core Laboratories N.V. was a trade of 32,912 Performance Shares done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,912 | 32,912 | - | - | Performance Shares | |
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 9,604 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 9,604 | 33,564 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Gwendolyn Y. Gresham | SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.31 per share. | 31 Dec 2024 | 5,989 | 27,575 (0%) | 0% | 17.3 | 103,670 | Common Stock |